Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212174 | PMC |
http://dx.doi.org/10.1136/bcr-2021-244365 | DOI Listing |
Am J Ophthalmol Case Rep
December 2024
From the Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Purpose: We describe the case of an 80-year-old man with bilateral minocycline-induced retinal pigment epithelium (RPE) hyperpigmentation, which initially masqueraded as AMD. Secondarily, using multimodal imaging features, we propose a mechanism for the development of minocycline-induced RPE hyperpigmentation.
Observations: The patient was referred with concern for AMD given the presence of macular drusenoid deposits on optical coherence tomography.
Infection
December 2024
Department of Infectious Diseases, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Dengakugakubo, Toyoake, Aichi, 4701192, Japan.
Acta Derm Venereol
December 2023
Division of Dermatology, Hitachi General Hospital, Ibaraki, Japan.
IDCases
October 2023
Department of Infectious Diseases, Aso Iizuka Hospital, 3-83 Yoshio, Iizuka, Fukuoka 820-8505, Japan.
A 75-year-old woman on hemodialysis for end-stage renal failure due to polycystic kidney disease developed dark spots on her limbs. She had been treated for extended spectrum beta-lactamase-producing Escherichia coli bacteremia by a rectovaginal fistula and was on long-term oral minocycline (cumulative dose 45 g). Physical examination revealed dark patches on her forearms and lower legs but no trunk hyperpigmentation or visual impairment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!